Zyn Nicotine Pouches Win Marketing Approval From FDA (2)

Jan. 16, 2025, 9:51 PM UTC

The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized nicotine pouches.

Zyn products, manufactured by Philip Morris International Inc., would lead to a lower risk of cancer than cigarettes and snus, which contains tobacco, the health watchdog said Thursday. Data showed nicotine pouches benefited adults who use cigarettes or smokeless tobacco products and switched to Zyn, it said.

Shares of Philip Morris rose 1.1% in New York on Thursday. They added 28% in 2024.

Still, the regulator warned that while the products could be legally marketed ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.